NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Astral Delivers In-Line Q4FY26 Performance, Guides Positive Outlook for FY27

Astral, a prominent player in the industry, has reported a broadly in-line performance in Q4FY26 with notable growth in revenue, EBITDA, and APAT. The company's revenue saw a year-on-year (y/y) growth of 24.2%, while EBITDA and APAT registered growth of 26.8% and 26.9%, respectively.

Notably, Astral has consistently demonstrated industry-leading volume growth and margin for the past three consecutive quarters. The management has expressed a positive outlook across various product segments for the fiscal year 2027 (FY27). Specifically, the company expects to gain significant market share in the CPVC pipe portfolio and improve the pipe segment margin by 200 basis points with the start of the CPVC resin backward integration project from Q4FY27.

Strong Growth Projections and Improved Margins

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

We expect Astral's earnings per share (EPS) to exhibit a strong compound annual growth rate (CAGR) of 32.3% over the period of FY26 to FY28e. Furthermore, the company's pre-tax return on invested capital (RoIC) is expected to remain healthy at 31%. These projections indicate a promising outlook for the company's future growth and profitability.

Revised Recommendation

We maintain a BUY rating on Astral with a revised target price (TP) of Rs1,800 (from Rs2,000 earlier). This revised TP values the company at 50x on FY28e EPS, compared to the previous valuation of 55x.

QuarterRevenue Growth (y/y)EBITDA Growth (y/y)APAT Growth (y/y)
Q4FY2624.2%26.8%26.9%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Note: The table above presents a comparison of Astral's Q4FY26 performance across revenue, EBITDA, and APAT growth.

Investor Takeaway

Maintain BUY rating on Astral Ltd with a revised target price of Rs1,800.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.